Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research Article

25-Hydroxyvitamin D3 1α-Hydroxylase Splice Variants in Breast Cell Lines MCF-7 and MCF-10

D. FISCHER, M. SEIFERT, S. BECKER, D. LÜDDERS, T. CORDES, J. REICHRATH and M. FRIEDRICH
Cancer Genomics & Proteomics July 2007, 4 (4) 295-300;
D. FISCHER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: dorle.fischer@web.de
M. SEIFERT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. BECKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. LÜDDERS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. CORDES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. REICHRATH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. FRIEDRICH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: It is known that 25(OH)D3 can be metabolized to 1,25(OH)2D3 by 1α-OHase in breast tissue. This tissue-specific expression of 1α-OHase may act as the pivotal link between vitamin D status (25(OH)D3 levels) and the anticancer effects of 1,25(OH)2D3. Alternative splicing frequently occurs in breast cancer cells; different splice variants of a given protein can display different biological functions and may cause tissue-specific variations. With this study it is the first time that expression and alternative splicing of 1α-OHase in the human breast cancer cell line MCF-7 and thebenign breast cell line MCF-10A are described. Materials and Methods: Expression of 1α-OHase RNA and protein was assessed using a real-time polymerase chain reaction (RT-PCR). The expression of 1α-OHase splice variants was detected by a highly specific PCR that combines nested and touchdown PCR. To determine which variants are translated in protein western blot analysis was carried out. Results: The expression of 1α-OHase was found to be 1.25-fold higher in MCF-7 compared to MCF-10A cells. In MCF-10A cells, at least 6 splice variants were detected whereas MCF-7 showed no or marginal expression levels of these variants. In MCF-7 cells the antibody detected a signal at 56 kDa corresponding to the size of normal 1α-OHase protein. In MCF-10A cells this signal was weaker. In western blot analysis at least two smaller variants at 45 kDa were found in MCF-7 cells. In MCF-10A cells at least 6 proteins between 37 and 56 kDa were detected with an only faint signal. Conclusion: We propose that alternative splicing of 1α-OHase can regulate the level of active enzyme. Splice variants may lead to a reduction of the protein. The significance of the smaller variants in MCF-7 cells has not been clarified either, but it is known that they are not able to use 25(OH)D3 as a substrate to generate 1,25(OH)D3. In MCF10A cells, more splice variants were identified, it may be that malignant cells contain inactive variants. How far they show a reduced activity remains unclear as no activity measurements were performed.

Keywords:
  • Vitamin D3
  • 1α-hydroxylase
  • splice variants
  • MCF-7
  • MCF-10

Footnotes

    • Received February 5, 2007.
    • Revision received March 23, 2007.
    • Accepted April 2, 2007.
  • Copyright© 2007 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 4 (4)
Cancer Genomics & Proteomics
Vol. 4, Issue 4
July-August 2007
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
25-Hydroxyvitamin D3 1α-Hydroxylase Splice Variants in Breast Cell Lines MCF-7 and MCF-10
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 7 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
25-Hydroxyvitamin D3 1α-Hydroxylase Splice Variants in Breast Cell Lines MCF-7 and MCF-10
D. FISCHER, M. SEIFERT, S. BECKER, D. LÜDDERS, T. CORDES, J. REICHRATH, M. FRIEDRICH
Cancer Genomics & Proteomics Jul 2007, 4 (4) 295-300;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
25-Hydroxyvitamin D3 1α-Hydroxylase Splice Variants in Breast Cell Lines MCF-7 and MCF-10
D. FISCHER, M. SEIFERT, S. BECKER, D. LÜDDERS, T. CORDES, J. REICHRATH, M. FRIEDRICH
Cancer Genomics & Proteomics Jul 2007, 4 (4) 295-300;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Alternative Splicing in the Cytochrome P450 Superfamily Expands Protein Diversity to Augment Gene Function and Redirect Human Drug Metabolism
  • Vitamin D Receptor Expression in Patients with Vulvar Cancer
  • Expression of Prostaglandin- and Vitamin D-metabolising Enzymes in Benign and Malignant Breast Cells
  • Vitamin D-24-Hydroxylase in Benign and Malignant Breast Tissue and Cell Lines
  • Google Scholar

Similar Articles

Cancer & Genome Proteomics

© 2022 Cancer Genomics & Proteomics

Powered by HighWire